Redness around a cut, biopsy, or surgical site can be part of healing. It can also reflect irritation, an allergy to an ointment or adhesive, or an infection that needs treatment. Because those possibilities overlap, a worsening wound-area rash is a poor place for self-diagnosis. The product history and the clinical exam belong together.
Why allergy and infection can look alike
Allergic contact dermatitis can cause itching, redness, swelling, small bumps or blisters, weeping, and spread beyond the exact wound. Irritant dermatitis can produce burning, dryness, or inflammation without immune sensitization. Infection can also cause redness and swelling; increasing pain, cloudy drainage, and fever are warning signs listed by the U.S. Centers for Disease Control and Prevention for surgical-site infection.
No single symptom settles the question. A wound may have more than one problem at once, and dressings, cleansers, adhesives, antiseptics, and topical medicines all contact already disrupted skin. Photographs and timing can help, but they do not replace an examination when infection is possible.
Put every product in the history
Neomycin and bacitracin are established contact allergens. Combination antibiotic ointments can contain one or both, along with polymyxin B and inactive ingredients. A person can also react to an adhesive, rubber chemical, preservative, or vehicle. Read the active and inactive ingredient lists instead of recording only a brand name.
Co-positivity needs careful language. An older clinical report found that bacitracin and neomycin often produced reactions in the same patients, but stated that this was co-reaction rather than immune cross-reaction. A positive neomycin patch test therefore does not automatically establish bacitracin allergy, and the reverse is also true. Each result still needs its own exposure and relevance assessment.
Hypothetical worked example
Five days after a biopsy, a person notices intense itch and a red rectangle under the dressing, plus redness where an antibiotic ointment spread. The shape suggests the adhesive and ointment both deserve review. If the wound is also increasingly painful or draining, infection remains in the differential. The useful next step is to photograph the area, gather the packages and written wound-care instructions, and contact the care team—not to run separate home challenges.
What a wound-care trial can and cannot prove
A randomized trial enrolled 922 people after dermatologic surgery; 884 were evaluable, with 440 in the white petrolatum group and 444 in the bacitracin group. Overall infection rates were not statistically significantly different. Four bacitracin patients and no petrolatum patients developed allergic contact dermatitis, also a nonsignificant difference. This result supports clinician guidance that uncomplicated dermatologic procedure wounds may not always need topical antibiotic prophylaxis. It does not prove that petrolatum is right for every wound, infection, burn, animal bite, surgical procedure, or person.
Follow the instructions for the specific wound. If a clinician prescribed a topical antibiotic, contact that clinician before changing or stopping it. Do not apply someone else’s prescription, leftover medicine, raw antibiotic powder, or a suspected product to unaffected skin as a test.
Document the pattern and call with specifics
- Record the procedure or injury date and when redness, itch, pain, swelling, or drainage began.
- Photograph the wound and the full rash edge in consistent lighting.
- List every cleanser, ointment, dressing, tape, glove, and topical medicine with application times.
- Note whether the rash matches the shape of tape, a pad, or the spread of an ointment.
- Tell the clinician about earlier patch-test results or reactions to topical antibiotics.
Contact the care team promptly for increasing redness or pain, cloudy drainage, fever, rapidly spreading symptoms, or any concern that the wound is infected. After urgent issues are addressed, persistent or recurring dermatitis may justify clinician-directed patch testing with a medicament or adhesive series selected from the exposure history.
Sources
- Smack DP, et al. Infection and Allergy Incidence in Ambulatory Surgery Patients Using White Petrolatum vs Bacitracin Ointment: A Randomized Controlled Trial. JAMA. 1996.
- Katz BE, Fisher AA. Bacitracin: a unique topical antibiotic sensitizer. Journal of the American Academy of Dermatology. 1987;17(6):1016–1024.
- U.S. Centers for Disease Control and Prevention. Surgical Site Infection Basics.
- Uter W, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing, update 2026.